THE SPC BLOG

RSS

A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life

thumbnail

C-443/17 - Abraxis CJEU Judgement

thumbnail

Forum Institut SPC Seminar 2019

thumbnail

Darunavir in Swedish Preliminary Injunction Proceedings

thumbnail

Update on SPCs in China

thumbnail

No more launch at risk in France?

thumbnail

Recent developments to the SPC manufacturing waiver proposal

thumbnail

Call for comments for C-673/18 (Santen v INPI)

thumbnail

C-443/17 - Abraxis - AG's opinion out

thumbnail

Germany - District Court lifts several ex-parte preliminary injunctions granted for Merck Sharpe & Dohme Corp.

thumbnail

An analysis of the CJEU’s ruling in Teva (C-121/2017) and a proposal for its implementation

thumbnail

C-527/17 ruling is out: No SPCs for CE-marked devices

thumbnail

France - Court of Appeal of Paris refers questions to the CJEU

thumbnail

UK - Truvada SPC does not comply with Article 3(a)

thumbnail

Combination SPCs: shaken and stirred - an article

thumbnail

C-121/17 - Teva ruling out now

For more from “THE SPC BLOG” please visit thespcblog.blogspot.com